Drug Master Files for: ALPRAZOLAM
✉ Email this page to a colleague
ALPRAZOLAM Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
18075 | A | II | 2/6/2005 | PAR A TECHNOLOGIES PRIVATE LTD | ALPRAZOLAM DRUG SUBSTANCE |
18214 | A | II | 3/30/2005 | MYLAN LABORATORIES LTD | ALPRAZOLAM USP |
20448 | A | II | 4/10/2007 | MALLADI DRUGS AND PHARMACEUTICALS LTD | ALPRAZOLAM |
20827 | A | II | 8/30/2007 | CENTAUR PHARMACEUTICALS PVT LTD | ALPRAZOLAM USP |
21828 | I | II | 7/10/2008 | LAKE CHEMICALS PRIVATE LTD | ALPRAZOLAM |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information